共 178 条
[1]
Andersson A(1996)Pharmacokinetics of cisplatin and its monohydrated complex in humans J Pharm Sci 85 824-827
[2]
Fagerberg J(2008)Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II J Clin Oncol 26 1879-1885
[3]
Lewensohn R(1994)Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties J Med Chem 37 408-414
[4]
Ehrsson H(2002)The role of retinoid X receptor messenger RNA expression in curatively resected non-small cell lung cancer Clin Cancer Res 8 438-443
[5]
Blumenschein GR(2005)Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis Carcinogenesis 26 525-530
[6]
Khuri FR(1993)Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity Cancer Surv 17 189-217
[7]
von Pawel J(1996)A decade of molecular biology of retinoic acid receptors Faseb J 10 940-954
[8]
Gatzemeier U(2001)Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: multinational phase II-III trial results J Clin Oncol 19 2456-2471
[9]
Miller WH(2002)Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer Cancer Chemother Pharmacol 49 48-56
[10]
Jotte RM(2005)The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells Lung Cancer 50 9-18